University of British Columbia
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1908-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ubc.ca
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Phase 4
- Conditions
- First Posted Date
- 2005-07-19
- Last Posted Date
- 2006-05-09
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 250
- Registration Number
- NCT00120978
- Locations
- π¨π¦
Wetaskiwin Lung Laboratory, Wetaskiwin, Alberta, Canada
π¨π¦Lion's Gate Hospital, North Vancouver, British Columbia, Canada
π¨π¦University of Alberta Hospital, Edmonton, Alberta, Canada
Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-06-15
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 40
- Registration Number
- NCT00114426
- Locations
- π¨π¦
University of Alberta Hospital, Edmonton, Alberta, Canada
Secondary Prevention of Small Subcortical Strokes Trial
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-04-24
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 3020
- Registration Number
- NCT00059306
- Locations
- πΊπΈ
Ohio State University, Division of Stroke, Columbus, Ohio, United States
πΊπΈMarshfield Clinic, Department of Neurology, Marshfield, Wisconsin, United States
πΊπΈMetrohealth Medical Center, Cleveland, Ohio, United States
Β© Copyright 2024. All Rights Reserved by MedPath